Macrolides and lincosamides in cattle and pigs: Use and development of antimicrobial resistance

Veterinary Journal

Volumn 200, Issue 2, 2014, Pages 230-239

  Pyörälä, Satu ^a   Baptiste, Keith Edward ^b   Catry, Boudewijn ^c   van Duijkeren, Engeline ^d   Greko, Christina ^e   Moreno, Miguel A ^f   Pomba, M Constança Matias Ferreira ^g   Rantala, Merja ^h   Ružauskas, Modestas ⁱ   Sanders, Pascal ^j   Threlfall, E John ^k   Torren Edo, Jordi ^l   Törneke, Karolina ^m  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Sundhedsstyrelsen   (Denmark)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e NATIONAL VETERINARY INSTITUTE   (Sweden)

^f UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^g FACULDADE DE MEDICINA VETERINÁRIA   (Portugal)

^h UNIVERSITY OF HELSINKI   (Finland)

ⁱ Lithuanian Veterinary Academy   (Lithuania)

^j Laboratoire de Fougères   (France)

^k PUBLIC HEALTH ENGLAND   (United Kingdom)

^l EUROPEAN MEDICINES AGENCY   (United Kingdom)

^m MEDICAL PRODUCTS AGENCY   (Sweden)

more..

Author keywords

Antimicrobial resistance; Consumption; Food animal; Lincosamides; Macrolides

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; COLISTIN; DALFOPRISTIN; ERYTHROMYCIN; GAMITHROMYCIN; JOSAMYCIN; LINCOMYCIN; LINCOSAMIDE; MACROLIDE; MIOKAMYCIN; OLEANDOMYCIN; PIRLIMYCIN; PRISTINAMYCIN; QUINUPRISTIN; ROKITAMYCIN; ROXITHROMYCIN; SPIRAMYCIN; SULFONAMIDE; TELITHROMYCIN; TILDIPIROSIN; TILMICOSIN; TRIMETHOPRIM; TULATHROMYCIN; TYLOSIN; TYLVALOSIN; UNINDEXED DRUG; VIRGINIAMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER; ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRITIS; BRACHYSPIRA; BRACHYSPIRA HYODYSENTERIAE; CAMPYLOBACTER JEJUNI; CATTLE; CLOSTRIDIUM DIFFICILE; DRUG APPROVAL; DRUG INDICATION; DRUG USE; DYSENTERY; ENTERITIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ENTEROPATHY; ESCHERICHIA COLI; EUROPE; FOOT DISEASE; GENITAL TRACT INFECTION; HISTOPHILUS SOMNI; KERATOCONJUNCTIVITIS; LEMIERRE SYNDROME; MANNHEIMIA HAEMOLYTICA; MASTITIS; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PASTEURELLA MULTOCIDA; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; SALMONELLA; SINGLE DRUG DOSE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HYICUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS SUIS; STREPTOCOCCUS UBERIS; SWINE; ANIMAL; BACTERIA; BOVINAE; CATTLE DISEASES; DRUG EFFECTS; MICROBIOLOGY; PHYSIOLOGY; SWINE DISEASES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CATTLE; CATTLE DISEASES; DRUG RESISTANCE, BACTERIAL; EUROPE; LINCOSAMIDES; MACROLIDES; SWINE; SWINE DISEASES;

EID: 84899924761     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.02.028     Document Type: Review

References (131)

1. Aarestrup F.M., Friis N.F. Antimicrobial susceptibility testing of Mycoplasma hyosynoviae isolated from pigs during 1968 to 1971 and during 1995 and 1996. Veterinary Microbiology 1998, 61:33-39.
2. Aarestrup F.M., Kempf I. Mycoplasma. Antimicrobial Resistance in Bacteria of Animal Origin 2006, 239-248. ASM Press, Washington, D.C. USA, pp. F.M. Aarestrup (Ed.).
3. Aarestrup F.M., Kruse H., Tast E., Hammerum A.M., Jensen L.B. Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway. Microbial Drug Resistance 2000, 6:63-70.
4. Aarestrup F.M., Nielsen E.M., Madsen M., Engberg J. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrobial Agents and Chemotherapy 1997, 41:2244-2250.
5. Aarestrup F.M., Schwarz S. Antimicrobial resistance in staphylococci and streptococci of animal origin. Antimicrobial Resistance in Bacteria of Animal Origin 2006, 187-212. ASM Press, Washington, DC, USA. F.M. Aarestrup (Ed.).
6. Achard A., Guerin-Faublee V., Pichereau V., Villers C., Leclercq R. Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene. Antimicrobial Agents and Chemotherapy 2008, 52:2767-2770.
7. AFSSA French Antimicrobial Resistance Monitoring Program for Bacteria of Animal Origin 2009, Report 2007-2008., Programme français 1999-2008, Vol. 2010. AFSSA.
8. Alfredson D.A., Korolik V. Antibiotic resistance and resistance mechanisms in Campylobacter jejuni and Campylobacter coli. FEMS Microbiology Letters 2007, 277:123-132.
9. Andini N., Nash K.A. Intrinsic macrolide resistance of the Mycobacterium tuberculosis complex is inducible. Antimicrobial Agents and Chemotherapy 2006, 50:2560-2562.
10. Anonymous Recommendations for the Use of Antimicrobial Agents in the Treatment of the Most Significant Infectious Diseases in Animals. Report of the Working Group on Antimicrobial Agents 2003, Ministry of Agriculture and Forestry in Finland, Helsinki.
11. Anonymous Formularia. Koninklijke Nederlandse Maatschappij Voor Diergeneeskunde accessed 13 September 2013. http://www.knmvd.nl/wvab/formularia/formularia.
12. Ballow C.H., Amsden G.W. Azithromycin: the first azalide antibiotic. The Annals of Pharmacotherapy 1992, 26:1253-1261.
13. Barcia-Macay M., Seral C., Mingeot-Leclercq M.P., Tulkens P.M., Van Bambeke F. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrobial Agents and Chemotherapy 2006, 50:841-851.
14. Barkema H.W., Schukken Y.H., Zadoks R.N. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. Journal of Dairy Science 2006, 89:1877-1895.
15. Belanger A.E., Shryock T.R. Macrolide-resistant Campylobacter: The meat of the matter. Journal of Antimicrobial Chemotherapy 2007, 60:715-723.
16. Boerlin P., Burnens A.P., Frey J., Kuhnert P., Nicolet J. Molecular epidemiology and genetic linkage of macrolide and aminoglycoside resistance in Staphylococcus intermedius of canine origin. Veterinary Microbiology 2001, 79:155-169.
17. Botrel M.A., Haenni M., Morignat E., Sulpice P., Madec J.Y., Calavas D. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhone-Alpes, France. Foodborne Pathogens and Disease 2010, 7:479-487.
18. Bryskier A., Butzler J.-P. Macrolides. Antibiotic and Chemotherapy: Anti-Infective Agents and Their Use in Therapy 2003, Churchill Livingstone, Edinburgh, UK. eighth ed.
19. Burch D.G., Duran C.O., Aarestrup F.M. Guidelines for antimicrobial use in swine. Guide to Antimicrobial Use in Animals 2008, 102-125. Blackwell Publishing, Oxford, UK.
20. BVL Berichte Zur Resistenzmonitoringstudie 2008 Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL), accessed 13 September 2013. http://www.bvl.bund.de/SharedDocs/Downloads/09_Untersuchungen/Archiv_berichte_Resistenzmonitoring/Bericht_Resistenzmonitoring_2008.pdf?__blob=publicationFile%26v=3.
21. Caldwell D.B., Wang Y., Lin J. Development, stability, and molecular mechanisms of macrolide resistance in Campylobacter jejuni. Antimicrobial Agents and Chemotherapy 2008, 52:3947-3954.
22. Catry B., Haesebrouck F., Vliegher S.D., Feyen B., Vanrobaeys M., Opsomer G., Schwarz S., Kruif A.D. Variability in acquired resistance of Pasteurella and Mannheimia isolates from the nasopharynx of calves, with particular reference to different herd types. Microbial Drug Resistance 2005, 11:387-394.
23. Clothier K.A., Kinyon J.M., Frana T.S., Naberhaus N., Bower L., Strait E.L., Schwartz K. Species characterization and minimum inhibitory concentration patterns of Brachyspira species isolates from swine with clinical disease. Journal of Veterinary Diagnostic Investigation 2011, 23:1140-1145.
24. CLSI VET01-A4. Performance standards for Antimicrobial disk and dilution susceptibility test for bacteria isolated from animals; Approved Standard 2013, Vol. 33. Wayne, PA, USA, Number 7. CLSI 2013. Fourth Ed.
25. Collignon P., Powers J.H., Chiller T.M., Aidara-Kane A., Aarestrup F.M. World Health Organization ranking of antimicrobials according to their importance in human medicine: A critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clinical Infectious Diseases 2009, 49:132-141.
26. Constable P., Pyörälä S., Smith G. Guidelines for antimicrobial use in cattle. Guide to Antimicrobial Use in Animals 2008, 143-160. Blackwell Publishing, Oxford, UK. L. Guardabassi, L.B. Jensen, H. Kruse (Eds.).
27. Culebras E., Rodriguez-Avial I., Betriu C., Picazo J.J. Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae. Journal of Antimicrobial Chemotherapy 2005, 56:836-840.
28. de Jong A., Bywater R., Butty P., Deroover E., Godinho K., Klein U., Marion H., Simjee S., Smets K., Thomas V., et al. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. Journal of Antimicrobial Chemotherapy 2009, 63:733-744.
29. DANMAP Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark accessed 13 September 2013. http://www.danmap.org/.
30. De Graef E.M., Decostere A., De Leener E., Goossens H., Baele M., Haesebrouck F. Prevalence and mechanism of resistance against macrolides, lincosamides, and streptogramins among Enterococcus faecium isolates from food-producing animals and hospital patients in Belgium. Microbial Drug Resistance 2007, 13:135-141.
31. Deluyker H.A., Van Oye S.N., Boucher J.F. Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows. Journal of Dairy Science 2005, 88:604-614.
32. Desmolaize B., Rose S., Warrass R., Douthwaite S. A novel Erm monomethyltransferase in antibiotic-resistant isolates of Mannheimia haemolytica and Pasteurella multocida. Molecular Microbiology 2011, 80:184-194.
33. Diner E.J., Hayes C.S. Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics. Journal of Molecular Biology 2009, 386:300-315.
34. Duinhof T.F., Dierikx C.M., Koene M.G., van Bergen M.A., Mevius D.J., Veldman K.T., van Beers-Schreurs H.M., de Winne R.T. Multiresistant Brachyspira hyodysenteriae in a Dutch sow herd]. Tijdschrift Voor Diergeneeskunde 2008, 133:604-608.
35. Edelstein P.H. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: Molecular mechanisms and resistance phenotypes. Clinical Infectious Diseases 2004, 38(Suppl. 4):S322-S327.
36. EFSA/ECDC The European Union Summary Report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2011. EFSA Journal 2013, 11:1253.
37. EMA Draxxin: EPAR - Product Information accessed 13 September 2013. http://www.ema.europa.eu/ema/.
38. EMA/CVMP/SAGAM Revised reflection Paper on the Use of 3rd and 4th Generation Cephalosporins in Food Producing Animals in the European Union: Development of Resistance and Impact on Human and Animal Health accessed 13 September 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004307.pdf.
39. EMA/CVMP/SAGAM Reflection Paper on the Use of Macrolides, Lincosamides and Streptogramins (MLS) in Food-Producing Animals in the European Union: Development of Resistance and Impact on Human and Animal Health accessed 13 September 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/11/WC500118230.pdf.
40. EMA/ESVAC In: European Medicines Agency, European Surveillance of Veterinary Antimicrobial Consumption. Sales of veterinary antimicrobial agents in 19 EU/EEA countries in 2010 (EMA/88728/2012) Second ESVAC report, accessed 13 September 2013. http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500133532.
41. EMA/ESVAC In: European Medicines Agency, European Surveillance of Veterinary Antimicrobial Consumption. Sales of veterinary antimicrobial agents in 25 EU/EEA countries in 2011 (EMA/236501/2013) Third ESVAC report, accessed 13 September 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Report/2013/10/WC500152311.pdf.
42. EMEA/CVMP Guideline on Pharmaceutical Fixed Combination Products accessed 13 September 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004645.pdf.
43. EMEA/CVMP Reflection Paper on the Use of Fluoroquinolones in Food Producing animals - Precautions for Use in the SPC Regarding Prudent use Guidance accessed 13 September 2013. http://www.ema.europa.eu/docs/en_GB/document_library/Other/2009/10/WC500005173.pdf.
44. Fessler A., Scott C., Kadlec K., Ehricht R., Monecke S., Schwarz S. Characterization of methicillin-resistant Staphylococcus aureus ST398 from cases of bovine mastitis. Journal of Antimicrobial Chemotherapy 2010, 65:619-625.
45. FINRES-Vet Finnish Veterinary Antimicrobial Resistance Monitoring and Consumption of Antimicrobial Agents in 1999, Helsinki, Finland 1999, Finnish Ministry of Agriculture and Forestry.
46. FINRES-Vet Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents in 2005-2006 accessed 13 September 2013. http://www.evira.fi/portal/en/evira/publications/?a=view%26productId=178.
47. Fossi M., Saranpaa T., Rautiainen E. In vitro sensitivity of the swine Brachyspira species to tiamulin in Finland 1995-1997. Acta Veterinaria Scandinavica 1999, 40:355-358.
48. Franklin A., Pringle M., Hampson D.J. Antimicrobial resistance in Clostridium and Brachyspira spp. and other anaerobes. Antimicrobial Resistance in Bacteria of Animal Origin 2006, 127-144. ASM Press, Washington, D.C. USA, pp. F.M. Aarestrup (Ed.).
49. Gerchman I., Levisohn S., Mikula I., Lysnyansky I. In vitro antimicrobial susceptibility of Mycoplasma bovis isolated in Israel from local and imported cattle. Veterinary Microbiology 2009, 137:268-275.
50. Gibreel A., Taylor D.E. Macrolide resistance in Campylobacter jejuni and Campylobacter coli. Journal of Antimicrobial Chemotherapy 2006, 58:243-255.
51. Giguère S., Huang R., Malinski T.J., Dorr P.M., Tessman R.K., Somerville B.A. Disposition of gamithromycin in plasma, pulmonary epithelial lining fluid, bronchoalveolar cells, and lung tissue in cattle. American Journal of Veterinary Research 2011, 72:326-330.
52. Giguère S. Macrolides, azalides and ketolides. Antimicrobial Therapy in Veterinary Medicine 2013, 211-232. Wiley Blackwell, Ames, IA, USA. Fifth Ed. S. Giguère, J.F. Prescott, P.M. Dowling (Eds.).
53. Giguère S. Lincosamides, pleuromutilins and streptogramins. Antimicrobial Therapy in Veterinary Medicine 2013, 199-210. Wiley Blackwell, Ames, IA, USA. Fifth Ed. S. Giguère, J.F. Prescott, P.M. Dowling (Eds.).
54. Gresham A.C., Hunt B.W., Dalziel R.W. Treatment of swine dysentery-problems of antibiotic resistance and concurrent salmonellosis. Veterinary Record 1998, 143:619.
55. Gullberg E., Cao S., Berg O.G., Ilbäck C., Sandegren L., Hughes D., Andersson D.I. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathogens 2011, 7:e1002158.
56. Gunell M., Kotilainen P., Jalava J., Huovinen P., Siitonen A., Hakanen A.J. In vitro activity of azithromycin against nontyphoidal Salmonella enterica. Antimicrobial Agents and Chemotherapy 2010, 54:3498-3501.
57. Gutierrez-Martin C.B., del Blanco N.G., Blanco M., Navas J., Rodriguez-Ferri E.F. Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Veterinary Microbiology 2006, 115:218-222.
58. Haenni M., Saras E., Chaussière S., Treilles M., Madec J.-Y. ermB-mediated erythromycin resistance in Streptococcus uberis from bovine mastitis. The Veterinary Journal 2011, 189:356-358.
59. Hardy D.J., Hensey D.M., Beyer J.M., Vojtko C., McDonald E.J., Fernandes P.B. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrobial Agents and Chemotherapy 1988, 32:1710-1719.
60. Hauschild T., Fessler A.T., Kadlec K., Billerbeck C., Schwarz S. Detection of the novel vga(E) gene in methicillin-resistant Staphylococcus aureus CC398 isolates from cattle and poultry. The Journal of Antimicrobial Chemotherapy 2012, 67:503-504.
61. Hendriksen R.S., Mevius D.J., Schroeter A., Teale C., Meunier D., Butaye P., Franco A., Utinane A., Amado A., Moreno M., et al. Prevalence of antimicrobial resistance among bacterial pathogens isolated from cattle in different European countries: 2002-2004. Acta Veterinaria Scandinavica 2008, 50:28.
62. Hidalgo A., Carvajal A., Garcia-Feliz C., Osorio J., Rubio P. Antimicrobial susceptibility testing of Spanish field isolates of Brachyspira hyodysenteriae. Research in Veterinary Science 2009, 87:7-12.
63. Hidalgo A., Carvajal A., Vester B., Pringle M., Naharro G., Rubio P. Trends towards lower antimicrobial susceptibility and characterization of acquired resistance among clinical isolates of Brachyspira hyodysenteriae in Spain. Antimicrobial Agents and Chemotherapy 2011, 55:3330-3337.
64. Jensen L.B., Frimodt-Moller N., Aarestrup F.M. Presence of erm gene classes in gram-positive bacteria of animal and human origin in Denmark. FEMS Microbiology Letters 1999, 170:151-158.
65. Jost B.H., Field A.C., Trinh H.T., Songer J.G., Billington S.J. Tylosin resistance in Arcanobacterium pyogenes is encoded by an erm X determinant. Antimicrobial Agents and Chemotherapy 2003, 47:3519-3524.
66. Juntunen P., Heiska H., Olkkola S., Myllyniemi A.L., Hanninen M.L. Antimicrobial resistance in Campylobacter coli selected by tylosin treatment at a pig farm. Veterinary Microbiology 2010, 146:90-97.
67. Kadlec K., Brenner Michael G., Sweeney M.T., Brzuszkiewicz E., Liesegang H., Daniel R., Watts J.L., Schwarz S. Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory disease. Antimicrobial Agents and Chemotherapy 2011, 55:2475-2477.
68. Kadlec K., Ehricht R., Monecke S., Steinacker U., Kaspar H., Mankertz J., Schwarz S. Diversity of antimicrobial resistance pheno- and genotypes of methicillin-resistant Staphylococcus aureus ST398 from diseased swine. Journal of Antimicrobial Chemotherapy 2009, 64:1156-1164.
69. Kadlec K., Schwarz S. Novel ABC transporter gene, vga(C), located on a multiresistance plasmid from a porcine methicillin-resistant Staphylococcus aureus ST398 strain. Antimicrobial Agents and Chemotherapy 2009, 53:3589-3591.
70. Kalmus P., Aasmae B., Karssin A., Orro T., Kask K. Udder pathogens and their resistance to antimicrobial agents in dairy cows in Estonia. Acta Veterinaria Scandinavica 2011, 53:4.
71. Karlsson M., Aspan A., Landen A., Franklin A. Further characterization of porcine Brachyspira hyodysenteriae isolates with decreased susceptibility to tiamulin. Journal of Medical Microbiology 2004, 53:281-285.
72. Karlsson M., Fellstrom C., Heldtander M.U., Johansson K.E., Franklin A. Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae. FEMS Microbiology Letters 1999, 172:255-260.
73. Karlsson M., Fellstrom C., Johansson K.E., Franklin A. Antimicrobial resistance in Brachyspira pilosicoli with special reference to point mutations in the 23S rRNA gene associated with macrolide and lincosamide resistance. Microbial Drug Resistance 2004, 10:204-208.
74. Kaspar H., Schroer U., Wallmann J. Quantitative resistance level (MIC) of Pasteurella multocida isolated from pigs between 2004 and 2006: National resistance monitoring by the BVL. Berliner und Munchener Tierärztliche Wochenschrift 2007, 120:442-451.
75. Keessen E.C., Hensgens M.P., Spigaglia P., Barbanti F., Sanders I.M., Kuijper E.J., Lipman L.J. Antimicrobial susceptibility profiles of human and piglet Clostridium difficile PCR-ribotype 078. Antimicrobial Resistance and Infection Control 2013, 2:14.
76. Kehrenberg C., Walker R.D., Wu C.C., Schwarz S. Antimicrobial resistance in members of the family Pasteurellaceae. Antimicrobial Resistance in Bacteria of Animal Origin 2006, 167-186. ASM Press, Washington, DC, USA. F.M. Aarestrup (Ed.).
77. Leclercq R., Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 1991, 35:1267-1272.
78. Li B., Wendlandt S., Yao J., Liu Y., Zhang Q., Shi Z., Wei J., Shao D., Schwarz S., Wang S., Ma Z. Detection and new genetic environment of the pleuromutilin-lincosamide-streptogramin A resistance gene lsa(E) in methicillin-resistant Staphylococcus aureus of swine origin. The Journal of Antimicrobial Chemotherapy 2013, 68:1251-1255.
79. Liu Y., Wang Y., Wu C., Shen Z., Schwarz S., Du X.D., Dai L., Zhang W., Zhang Q., Shen J. First report of the multidrug resistance gene cfr in Enterococcus faecalis of animal origin. Antimicrobial Agents and Chemotherapy 2012, 56:1650-1654.
80. Lobova D., Smola J., Cizek A. Decreased susceptibility to tiamulin and valnemulin among Czech isolates of Brachyspira hyodysenteriae. Journal of Medical Microbiology 2004, 53:287-291.
81. Loch I.M., Glenn K., Zadoks R.N. Macrolide and lincosamide resistance genes of environmental streptococci from bovine milk. Veterinary Microbiology 2005, 111:133-138.
82. Luthje P., Schwarz S. Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes. The Journal of Antimicrobial Chemotherapy 2006, 57:966-969.
83. Luthje P., Schwarz S. Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet. International Journal of Antimicrobial Agents 2007, 29:528-535.
84. Luthje P., von Kockritz-Blickwede M., Schwarz S. Identification and characterization of nine novel types of small staphylococcal plasmids carrying the lincosamide nucleotidyltransferase gene lnu(A). The Journal of Antimicrobial Chemotherapy 2007, 59:600-606.
85. Madgwick L., Mayer S., Keen P. Penetration of antibiotics into bovine neutrophils and their activity against intracellular Staphylococcus aureus. The Journal of Antimicrobial Chemotherapy 1989, 24:709-718.
86. Martel A., Baele M., Devriese L.A., Goossens H., Wisselink H.J., Decostere A., Haesebrouck F. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates. Veterinary Microbiology 2001, 83:287-297.
87. Martel A., Devriese L.A., Decostere A., Haesebrouck F. Presence of macrolide resistance genes in streptococci and enterococci isolated from pigs and pork carcasses. International Journal of Food Microbiology 2003, 84:27-32.
88. MARAN Monitoring of Antimicrobial Resistance and Antimicrobial Usage in The Netherlands in 2006-2008 accessed 13 September 2013. http://www.wageningenur.nl/en/Expertise-Services/Research-Institutes/central-veterinary-institute/Publications-CVI.htm.
89. MARAN Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in The Netherlands in 2012 accessed 13 September 2013. http://www.wageningenur.nl/upload_mm/7/8/9/52388c6c-858c-483c-b57d-227029fe778a_005738_Nethmap_2013%20def_web.pdf.
90. Menge M., Rose M., Bohland C., Zschiesche E., Kilp S., Metz W., Allan M., Röpke R., Nürnberger M. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, nonanesthetized cattle). Journal of Veterinary Pharmacology and Therapeutics 2012, 35:550-559.
91. Middleton J.R., Bader G.R., Corbett R.B. Use of Pulsed-Field Gel Electrophoresis to Evaluate the Success of Treatment of Staphylococcus aureus Mastitis 2007, NMC Annual Meeting Proceedings. NMC National Mastitis Council. Annual Meeting. 202-203.
92. Morar M., Pengelly K., Koteva K., Wright G.D. Mechanism and diversity of the erythromycin esterase family of enzymes. Biochemistry 2012, 51:1740-1751.
93. NORM-VET Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway accessed 13 September 2013. http://www.vetinst.no/eng/Research/Publications/Norm-Norm-Vet-Report.
94. Palmieri C., Magi G., Creti R., Baldassarri L., Imperi M., Gherardi G., Facinelli B. Interspecies mobilization of an ermT-carrying plasmid of Streptococcus dysgalactiae subsp. equisimilis by a coresident ICE of the ICESa2603 family. Journal of Antimicrobial Chemotherapy 2013, 68:23-26.
95. Palmieri C., Ratsch I.M., Princivalli M.S., Candelaresi C., Magi G., Spinaci C., Coppa G.V., Facinelli B. erm(A)-mediated macrolide resistance and ability to invade human respiratory cells in a Streptococcus dysgalactiae subspecies equisimilis pharyngeal isolate. Journal of Antimicrobial Chemotherapy 2007, 60:1405-1406.
96. Payot S., Bolla J.M., Corcoran D., Fanning S., Megraud F., Zhang Q. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes and Infection 2006, 8:1967-1971.
97. Pitkala A., Haveri M., Pyörälä S., Myllys V., Honkanen-Buzalski T. Bovine mastitis in Finland 2001 - prevalence, distribution of bacteria, and antimicrobial resistance. Journal of Dairy Science 2004, 87:2433-2441.
98. Portis E., Lindeman C., Johansen L., Stoltman G. A ten-year (2000-2009) study of antimicrobial susceptibility of bacteria that cause bovine respiratory disease complex - Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni - in the United States and Canada. Journal of Veterinary Diagnostic Investigation 2012, 24:932-944.
99. Prescott F. History of antimicrobial usage in agriculture: an overview. Guide to Antimicrobial Use in Animals 2008, 19-28. Blackwell Publishing, Oxford, UK. L. Guardabassi, L.B. Jensen, H. Kruse (Eds.).
100. Pringle M., Aarestrup F.M., Bergsjo B., Fossi M., Jouy E., Landen A., Mevius D., Perry K., Teale C., Thomson J., et al. Quality-control ranges for antimicrobial susceptibility testing by broth dilution of the Brachyspira hyodysenteriae type strain (ATCC 27164T). Microbial Drug Resistance 2006, 12:219-221.
101. Pringle M., Landen A., Franklin A. Tiamulin resistance in porcine Brachyspira pilosicoli isolates. Research in Veterinary Science 2006, 80:1-4.
102. Pringle M., Landen A., Unnerstad H.E., Molander B., Bengtsson B. Antimicrobial susceptibility of porcine Brachyspira hyodysenteriae and Brachyspira pilosicoli isolated in Sweden between 1990 and 2010. Acta Veterinaria Scandinavica 2012, 54:54.
103. Pyörälä S.H., Pyörälä E.O. Efficacy of parenteral administration of three antimicrobial agents in treatment of clinical mastitis in lactating cows: 487 cases (1989-1995). Journal of the American Veterinary Medical Association 1998, 212:407-412.
104. Roberts M.C. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiology Letters 2008, 282:147-159.
105. Roberts M.C. Environmental macrolide-lincosamide-streptogramin and tetracycline resistant bacteria. Frontiers in Microbiology 2011, 2:40.
106. Rose M., Menge M., Bohland C., Zschiesche E., Wilhelm C., Kilp S., Metz W., Allan M., Ropke R., Nurnberger M. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae. Journal of Veterinary Pharmacology and Therapeutics 2013, 36:140-153.
107. Sampimon O.C., Lam T.J., Mevius D.J., Schukken Y.H., Zadoks R.N. Antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine milk samples. Veterinary Microbiology 2011, 150:173-179.
108. Schmitt-Van de Leemput E., Zadoks R.N. Genotypic and phenotypic detection of macrolide and lincosamide resistance in Streptococcus uberis. Journal of Dairy Science 2007, 90:5089-5096.
109. Schultz K.K., Strait E.L., Erickson B.Z., Levy N. Optimization of an antibiotic sensitivity assay for Mycoplasma hyosynoviae and susceptibility profiles of field isolates from 1997 to 2011. Veterinary Microbiology 2012, 158:104-108.
110. Schwarz S., Kehrenberg C., Ojo K.K. Staphylococcus sciuri gene erm(33), encoding inducible resistance to macrolides, lincosamides, and streptogramin B antibiotics, is a product of recombination between erm(C) and erm(A). Antimicrobial Agents and Chemotherapy 2002, 46:3621-3623.
111. Schwarz S., Silley P., Simjee S., Woodford N., van Duijkeren E., Johnson A.P., Gaastra W. Assessing the antimicrobial susceptibility of bacteria obtained from animals. Veterinary Microbiology 2010, 141:1-4.
112. Schwendener S., Perreten V. New transposon Tn6133 in methicillin-resistant Staphylococcus aureus ST398 contains vga (E), a novel streptogramin A, pleuromutilin, and lincosamide resistance gene. Antimicrobial Agents and Chemotherapy 2011, 55:4900-4904.
113. Scorneaux B., Shryock T.R. The determination of the cellular volume of avian, porcine and bovine phagocytes and bovine mammary epithelial cells and its relationship to uptake of tilmicosin. Journal of Veterinary Pharmacology and Therapeutics 1999, 22:6-12.
114. Seral C., Van Bambeke F., Tulkens P.M. Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrobial Agents and Chemotherapy 2003, 47:2283-2292.
115. Shen J., Wang Y., Schwarz S. Presence and dissemination of the multiresistance gene cfr in Gram-positive and Gram-negative bacteria. The Journal of Antimicrobial Chemotherapy 2013, 68:1697-1706.
116. Stakenborg T., Vicca J., Butaye P., Maes D., Minion F.C., Peeters J., De Kruif A., Haesebrouck F. Characterization of in vivo acquired resistance of Mycoplasma hyopneumoniae to macrolides and lincosamides. Microbial Drug Resistance 2005, 11:290-294.
117. SVARM Swedish Veterinary Antimicrobial Resistance Monitoring accessed 13 September 2013. http://www.sva.se/en/About-SVA/Reports-and-publications-in-english/Antibiotikaresistens/SVARM-rapporter/.
118. Thomas A., Nicolas C., Dizier I., Mainil J., Linden A. Antibiotic susceptibilities of recent isolates of Mycoplasma bovis in Belgium. Veterinary Record 2003, 153:428-431.
119. van Hoek A.H., Mevius D., Guerra B., Mullany P., Roberts A.P., Aarts H.J. Acquired antibiotic resistance genes: An overview. Frontiers in Microbiology 2011, 2:203.
120. Vaara M. Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. Antimicrobial Agents and Chemotherapy 1993, 37:354-356.
121. Van Looveren M., Daube G., De Zutter L., Dumont J.M., Lammens C., Wijdooghe M., Vandamme P., Jouret M., Cornelis M., Goossens H. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. The Journal of Antimicrobial Chemotherapy 2001, 48:235-240.
122. Vester B., Douthwaite S. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrobial Agents and Chemotherapy 2001, 45:1-12.
123. Vicca J., Stakenborg T., Maes D., Butaye P., Peeters J., de Kruif A., Haesebrouck F. In vitro susceptibilities of Mycoplasma hyopneumoniae field isolates. Antimicrobial Agents and Chemotherapy 2004, 48:4470-4472.
124. Vyt P., Hommez J. Antimicrobial susceptibility of Brachyspira hyodysenteriae isolates compared with the clinical effect of treatment. Vlaams Diergeneeskundig Tijdschrift 2006, 75:279-285.
125. Wattanaphansak S., Singer R.S., Gebhart C.J. In vitro antimicrobial activity against 10 North American and European Lawsonia intracellularis isolates. Veterinary Microbiology 2009, 134:305-310.
126. Werckenthin C., Cardoso M., Martel J.L., Schwarz S. Antimicrobial resistance in staphylococci from animals with particular reference to bovine Staphylococcus aureus, porcine Staphylococcus hyicus, and canine Staphylococcus intermedius. Veterinary Research 2001, 32:341-362.
127. WHO WHO list of Critically Important Antimicrobials in Human Medicine. Third Revision accessed 13 September 2013. http://apps.who.int/iris/bitstream/10665/77376/1/9789241504485_eng.pdf.
128. Witte W., Cuny C. Emergence and spread of cfr-mediated multiresistance in staphylococci: An interdisciplinary challenge. Future Microbiology 2011, 6:925-931.
129. Yao J., Moellering C.J. Antibacterial agents. Manual of Clinical Microbiology 2007, 1077-1113. ASM Press, Washington, DC, USA. Ninth Ed. P. Murray (Ed.).
130. Zastempowska E., Lassa H. Genotypic characterization and evaluation of an antibiotic resistance of Trueperella pyogenes (Arcanobacterium pyogenes) isolated from milk of dairy cows with clinical mastitis. Veterinary Microbiology 2012, 161:153-158.
131. Zhang W.J., Xu X.R., Schwarz S., Wang X.M., Dai L., Zheng H.J., Liu S. Characterization of the IncA/C plasmid pSCEC2 from Escherichia coli of swine origin that harbours the multiresistance gene cfr. The Journal of Antimicrobial Chemotherapy 2014, 69:385-389.